For those with Migraines, the question of whether to use hormone therapies is one we often look at only in terms of the impact it will have on Migraine frequency and severity. There are, however other issues that need to be considered as well.
Two new studies show that hormone therapy (HT) for women is linked to brain shrinkage, but not to the small brain lesions that are the first sign of cerebrovascular disease. The studies are published in the January 13, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Earlier studies showed that estrogen with or without added progestin increased the risk for developing dementia and cognitive decline, or difficulty with thinking skills and memory in women age 65 and older.
This is an article for all Migraineurs considering hormone therapy. Click HERE to read the full article.
Live well,
Teri
Comments